MetaCap

Rentokil Initial Cash Flow Statement

NYSE: RTOConsumer DiscretionaryOther Consumer ServicesUSD

20.24-0.01 (-0.05%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Rentokil Initial free cash flow

In fiscal 2025, Rentokil Initial generated $972.0 million of operating cash flow and spent $208.0 million on capital expenditures. That left free cash flow of $764.0 million, a free-cash-flow margin of 11.1% of revenue. Free cash flow was up 17.7% from the prior year's $649.0 million.

Rentokil Initial returned $304.0 million to shareholders through dividends, equal to 40% of free cash flow. Free cash flow covered dividend payments 2.5 times.

Summary generated from market data by MetaCap's automated system. Methodology

Rentokil Initial cash flow statement (annual)

Rentokil Initial annual cash flow statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31
Net Income470.00M392.00M474.00M
Net Income growth (YoY)+19.90%-17.30%—
Operating Cash Flow972.00M868.00M916.00M
Capital Expenditures-208.00M-219.00M-207.00M
Investing Cash Flow26.00M-476.00M-514.00M
Dividends Paid-304.00M-292.00M-252.00M
Debt Issued1.23B0—
Debt Repaid-700.00M-464.00M—
Financing Cash Flow27.00M-952.00M-451.00M
Free Cash Flow764.00M649.00M709.00M

This table shows 3 annual periods of Rentokil Initial's cash flow statement, from FY 2025 back to FY 2023, across 9 line items including net income, operating cash flow, capital expenditures. Values in USD; B = billions, M = millions. Fiscal periods follow RTO's reporting calendar. What is a cash flow statement?

More financial data